ESP Equity Partners
3
22M
1
0.67
1
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Bedminster.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2012. The important activity for fund was in 2007.
We also calculated 1 valuable employee in our database.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the ESP Equity Partners, startups are often financed by NewSpring Ventures. The meaningful sponsors for the fund in investment in the same round are Quaker BioVentures, NewSpring Ventures, NewSpring Capital. In the next rounds fund is usually obtained by Quaker BioVentures, NewSpring Capital, Merrill Lynch.
Among the most popular portfolio startups of the fund, we may highlight EKR Therapeutics. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.67
- Investments by industry
- Pharmaceuticals (3)
- Pharmaceutical (3)
- Health Care (3)
- Therapeutic Devices (3)
- Biotechnology (3) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 150M
- Group Appearance index
- 1.00
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.92
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EKR Therapeutics | 15 Aug 2007 | Therapeutic Devices, Biotechnology, Pharmaceuticals, Health Care, Pharmaceutical, Therapeutics | Late Stage Venture | 13M | United States, New Jersey |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.